AHSG and metabolic dysfunction-associated steatotic liver disease: Previous studies have revealed that an elevation in fetuin-A levels is associated with an increased risk of developing numerous childhood metabolic consequences of IR, including T2DM, nonalcoholic fatty liver disease (NAFLD), polycystic ovary syndrome, and excessive fetal growth [7,8,9,10].